Antibody drug conjugates (ADC) that bind to 161P2F10B proteins
Details for Australian Patent Application No. 2011213609 (hide)
International Classifications
Event Publications
16 August 2012 PCT application entered the National Phase
PCT publication WO2011/097627 Priority application(s): WO2011/097627
6 September 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 01 Aug 2012 2011214096 BP EXPLORATION OPERATING COMPANY LIMITED The nature of the amendment is as shown in the statement(s) filed 09 Aug 2012
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2011213616-Low-permeability, laser-activated drug delivery device
2011213607-Valving system and method of selectively halting injection of chemicals
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser